You are here

Subscribe

Prostate & Urologic Cancer Center Blog

All
All

DCI Center for Prostate & Urologic Cancers Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Jessica Hyland, Editor-In-Chief.

NIH Awards $2.5 Million For Prostate Cancer Research

A group of researchers led by Andrew Armstrong, MD, MSc, professor of medicine and surgery at Duke Cancer Institute, has recently been awarded $2,500,000 from the National Institutes of Health (NIH) to investigate the connection between hormonal resistance in prostate cancer with metastasis and...

PHEN Hosts 2019 Prostate Cancer Disparity Summit

The Prostate Health Education Network (PHEN) will host the 15th Annual African American Prostate Cancer Disparity Summit in Washington, DC, on September 12 – 13, 2019. Daniel George, MD, will present on “The African American Disparity – Biology or Access?” The two-day summit connects prostate...

Enzalutamide Significantly Improves Progression-Free Survival in Men with Metastatic Prostate Cancer

A multi-institutional group of clinical researchers, led by Duke Cancer Institute’s Andrew Armstrong, MD, MSc, FACP, published a new report this month in the Journal of Clinical Oncology (JCO) that describes results from the ARCHES study. ARCHES prospectively studied and evaluated the efficacy and...

With Robust Molecular Tumor Registry "MrT," The Stars Align

Some of the newest and most exciting cancer drugs target tumors that have a specific genetic mutation or characteristic. These targeted therapies block the growth and spread of cancer by interfering with specific molecular targets on those tumors that are involved in the growth, progression and...

DOD Awards $1.6 Million To Study Health Disparity in Prostate Cancer

A group of researchers led by Daniel George, MD, professor of medicine and surgery at Duke Cancer Institute, have recently been awarded $1,609,691 from the Department of Defense Prostate Cancer Research Program ( PCRP ) to study health disparity in metastatic prostate cancer. George’s project is...

Controversies In Prostate Cancer Treatment & Screening (3.27.19)

Social scientist Jenny Donovan, PhD, FMedSci, a visiting scholar at the Durham VA Health System's Cooperative Studies Program Epidemiology Center (CSPEC) and Duke University, will deliver a talk on "Randomized trials for controversies in prostate cancer treatment and screening: recruitment and...

Duke Abstracts Accepted For Presentation At 2019 GU ASCO Symposium

The DCI Center for Prostate & Urologic Cancers has 18 abstracts accepted for presentation at the 2019 Genitourinary Cancers (GU) Symposium of the American Society of Clinical Oncology (ASCO) taking place Thursday, Feb. 14 through Saturday, Feb. 16 in San Francisco, California. Held annually,...

Study Signals Survival Benefit for Black Men on New Prostate Cancer Drugs

It used to be a statistical fact that African-American men fared worse than whites when battling prostate cancer. But recent research led by scientists at the Duke Cancer Institute has been challenging that notion. Added evidence will be presented Feb. 11 at a meeting of the American Society of...

New Prostate Cancer Prognostic Model For Enzalutamide

Researchers at the Duke Prostate & Urologic Cancer Center, led by genitourinary oncologist Andrew Armstrong, MD, have recently developed a novel nomogram, a prognostic model that measures overall survival for men with metastatic prostate cancer who were treated with enzalutamide, according to...

The Relationship of the B7H3 Immune Checkpoint to Prostate Cancer Outcomes

Prostate cancer is known to be an immune evasive tumor, often coexisting with areas of inflammation in the primary site, but without over-expression of the traditional PD-1/PD-L1 immune checkpoint, unlike many other cancer subtypes. While certain prostate cancer subsets like microsatellite high (...

Somarelli Awarded Prostate Cancer Research Funding

A team of researchers led by Duke Cancer Institute scientist Jason Somarelli, PhD, has been awarded a Prostate Cancer Research Program (PCRP) Idea Development Award — New Investigator, totaling $350,000, by the United States Department of Defense Office of Congressionally Directed Medical Research...

Can Your Treatment Regimen Affect Your Cardiovascular Health?

Nestled in the woods of Duke Forest, you will find the Center for Living Campus at Duke University. It’s an early spring morning as Harry “Randy” Chambers arrives for his weekly exercise appointment. Once inside the building’s walls, Chambers begins to warms up with a brisk walk around the track. “...

Pages